127 related articles for article (PubMed ID: 7087161)
1. Effect of the vasodilator therapy in regurgitant valvular disease.
Sasayama S; Ohyagi A; Lee JD; Nonogi H; Sakurai T; Wakabayashi A; Fujita M; Kawai C
Jpn Circ J; 1982 Apr; 46(4):433-41. PubMed ID: 7087161
[TBL] [Abstract][Full Text] [Related]
2. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.
Miller RR; Vismara LA; DeMaria AN; Salel AF; Mason DT
Am J Cardiol; 1976 Nov; 38(5):564-7. PubMed ID: 983953
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation.
Bolen JL; Alderman EL
Circulation; 1976 May; 53(5):879-83. PubMed ID: 1260993
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intraoperative nitroprusside unloading in mitral and aortic regurgitation.
Stone JG; Hoar PF; Faltas AN; Johnson LL; Edie RN; Bowman FO; Malm JR
J Thorac Cardiovasc Surg; 1979 Jul; 78(1):103-9. PubMed ID: 449373
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
Levine HJ; Gaasch WH
J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of reduction of mitral regurgitation with vasodilator therapy.
Yoran C; Yellin EL; Becker RM; Gabbay S; Frater RW; Sonnenblick EH
Am J Cardiol; 1979 Apr; 43(4):773-7. PubMed ID: 425914
[TBL] [Abstract][Full Text] [Related]
7. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Weiland DS; Konstam MA; Salem DN; Martin TT; Cohen SR; Zile MR; Das D
Am J Cardiol; 1986 Nov; 58(10):1046-50. PubMed ID: 3776843
[TBL] [Abstract][Full Text] [Related]
8. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure.
Stevenson LW; Brunken RC; Belil D; Grover-McKay M; Schwaiger M; Schelbert HR; Tillisch JH
J Am Coll Cardiol; 1990 Jan; 15(1):174-80. PubMed ID: 2295730
[TBL] [Abstract][Full Text] [Related]
9. Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin.
Harshaw CW; Grossman W; Munro AB; McLaurin LP
Ann Intern Med; 1975 Sep; 83(3):312-6. PubMed ID: 1180426
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
11. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area.
Yoran C; Yellin EL; Becker RM; Gabbay S; Frater RW; Sonnenblick EH
Circulation; 1979 Jul; 60(1):170-6. PubMed ID: 445720
[TBL] [Abstract][Full Text] [Related]
12. [The relationships between left ventricular volumes and ejection fraction in mitral and aortic regurgitation (author's transl)].
Strauer BE; Kramer H; Bolte H; Riecker G
Klin Wochenschr; 1975 Oct; 53(20):795-84. PubMed ID: 1202276
[TBL] [Abstract][Full Text] [Related]
13. Myocardial mechanics in aortic and mitral valvular regurgitation: the concept of instantaneous impedance as a determinant of the performance of the intact heart.
Urschel CW; Covell JW; Sonnenblick EH; Ross J; Braunwald E
J Clin Invest; 1968 Apr; 47(4):867-83. PubMed ID: 5641623
[TBL] [Abstract][Full Text] [Related]
14. Effects of afterload reduction on vena contracta width in mitral regurgitation.
Kizilbash AM; Willett DL; Brickner ME; Heinle SK; Grayburn PA
J Am Coll Cardiol; 1998 Aug; 32(2):427-31. PubMed ID: 9708471
[TBL] [Abstract][Full Text] [Related]
15. Load dependence of the effective regurgitant orifice area in a sheep model of aortic regurgitation.
Reimold SC; Byrne JG; Caguioa ES; Lee CC; Laurence RG; Peigh PS; Cohn LH; Lee RT
J Am Coll Cardiol; 1991 Oct; 18(4):1085-90. PubMed ID: 1832697
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of hydralazine in severe mitral regurgitation.
Greenberg BH; Massie BM; Brundage BH; Botvinick EH; Parmley WW; Chatterjee K
Circulation; 1978 Aug; 58(2):273-9. PubMed ID: 668075
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation.
Shen WF; Roubin GS; Hirasawa K; Uren RF; Hutton BF; Harris PJ; Fletcher PJ; Kelly DT
J Am Coll Cardiol; 1984 Nov; 4(5):902-7. PubMed ID: 6491083
[TBL] [Abstract][Full Text] [Related]
19. Effects of heart rate on experimentally produced mitral regurgitation in dogs.
Yoran C; Yellin EL; Hori M; Tsujioka K; Laniado S; Sonnenblick EH; Frater RW
Am J Cardiol; 1983 Dec; 52(10):1345-9. PubMed ID: 6650422
[TBL] [Abstract][Full Text] [Related]
20. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
